Recruiting Myelofibrosis Studies in St Louis
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK inhibitor. Inhibition...
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofi...
About Myelofibrosis Clinical Trials in St Louis
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 2 myelofibrosis clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 535 participants. Research is being sponsored by Kartos Therapeutics, Inc., Disc Medicine, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in St Louis — FAQ
Are there myelofibrosis clinical trials in St Louis?
Yes, there are 2 myelofibrosis clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in St Louis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.
Are clinical trials in St Louis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 2 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov